OmniAb Investor Presentation Deck

The OmniAb Platform LICENSES TO OUR TECHNOLOGY PLATFORM ARE STRUCTURED TO ALIGN ECONOMIC AND SCIENTIFIC INTERESTS WITH OUR PARTNERS Create Diverse Antibody Repertoires Create Diverse Repertoires of High-Quality Naturally-Optimized Antibodies Screen Antibody Candidates Screen Millions of Cells to Find Potential Therapeutic Candidates Technology offering addresses critical industry needs and is paired with our highly specialized and efficient operations Identify the Right Antibody Further Characterize, Select & Optimize the Right Antibody We leverage our proprietary and differentiated technologies, rather than commoditized industry services that are widely available from CROS or built into big pharma 11 OmniAb

View entire presentation